AZTA

NASD Azenta, Inc.

Nov 4, 2026 · 1:58 PM ET DELAYED Market Open

$38.59 ↑ +1.45 (+3.90%) Trading Up from the previous close of $37.14, $1.02 below the day’s high of $39.61

YTD change: +16.03%
vs 20-day SMA: +3.91%
vs 200-day SMA: +36.21%

Price ranges

Previous day

$35.05 $37.44

open $35.66 close $37.14

+$1.48 (+4.15%)

Today

$37.66 $39.61

open $38.51 now $38.59

+$0.08 (+0.21%)

Past week

$35.05 $41.71

from $39.08 now $38.59

-$0.49 (-1.25%)

Past month

$33.03 $41.71

from $39.35 now $38.59

-$0.76 (-1.93%)

This year

$15.93 $46.41

from $33.26 now $38.59

+$5.33 (+16.03%)

Price & Performance

+12.81 (+52.65%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 67.3% away from all-time highs of $118.13
AZTA is up 16% since the beginning of the year
AZTA is up 28% over the past 12 months
AZTA is down 2% over the past 1 month
12% of all AZTA investors are betting against AZTA

AZTA reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +23.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.16

Earnings momentum -44.2% Quarterly EPS growth

Quarterly change -44.2%

Valuation

P/E ratio N/A

Enterprise value $1.4B

Beta 2.12

Balance sheet & scale

IncomeN/A

Revenue$613.6M

Cash$328.2M

Debt$54.0K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $1.7B

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Competitor comparison

Ticker	Company	Price	Change
REGN	Regeneron Pharmaceuticals, Inc.	$973.36	+1.26%
IQV	IQVIA Holdings Inc	$262.59	+1.61%
CRL	Charles River Laboratories International, Inc.	$351.87	+3.94%
ICLR	ICON Plc	$203.77	-0.67%
IT	Gartner, Inc.	$204.22	-13.19%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.